Pre-earnings options volume in Assertio Therapeutics is 1.8x normal with calls leading puts 13:2. Implied volatility suggests the market is anticipating a move near 29.1%, or 28c, after results are released. Median move over the past eight quarters is 10.4%.
Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
The Fly
Assertio Therapeutics options imply 29.1% move in share price post-earnings
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App